Research Purposes Only. NOT FOR HUMAN CONSUMPTION
$60.00 – $275.00
Retatrutide is an investigational synthetic peptide designed as a triple agonist targeting glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. Composed of 39 amino acids, it mimics these hormones to regulate blood sugar, suppress appetite, and increase energy expenditure. It’s primarily researched for obesity and type 2 diabetes, showing significant weight loss (up to 24.2% over 48 weeks) and improved glycemic control in phase 2 trials.
THIS IS NOT FOR HUMAN CONSUMPTION. SOLD FOR RESEARCH ONLY!
By pressing the button “Subscribe”, you confirm that you have read
and are agreeing to our Terms of Service regarding the storage of the
data submitted through this form.
Please note that all products featured on this website are intended exclusively for research and development purposes. They are not designed for any form of human consumption. The claims made on this website have not undergone evaluation by the U.S. Food and Drug Administration.
Neither the statements nor the products of this company aim to diagnose, treat, cure, or ward off any disease.
Penguin Peptides is a chemical supplier. Penguin Peptides is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. Penguin Peptides is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic act.